PFIZER INC 4

Albert Bourla (Chairman & CEO of Pfizer Inc.) bought 38,000 shares of Pfizer common stock at about $26.34 per share, totaling roughly $1.0 million.

On August 12, 2026, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 38,000 shares of Pfizer common stock in a transaction reported as a Code P (open market or private purchase) at a price of $26.34 per share, for an estimated total cost of about $1.00 million. Following this purchase, his directly held ownership increased to 429,173 shares, while an additional 6,382 shares are reported as indirectly owned under a Rule 16b-3 plan. Based on the current stock price of approximately $26.42, Bourla’s direct holdings are worth about $11.34 million, and his indirect holdings are worth about $0.17 million, indicating a meaningful insider purchase that modestly increases his economic exposure to the company.

Filing Facts

CIK

78003

Ticker

PFE

Form

4

Source Type

fda

Accession

0001225208-26-007083

Alert Tier

8